OBJECTIVE: Neoaortic arch obstruction after stage I palliation is an important risk factor affecting interstage mortality in patients with hypoplastic left heart syndrome, with no accepted standard surgical approach. We sought to determine the efficacy of different techniques for aortic arch reconstruction to reduce the incidence of postoperative neoaortic arch obstruction. METHODS: From January 2000 through June 2005, 210 patients underwent stage I palliation. To enlarge the aortic arch, 12 (6%) patients had a direct connection, 115 (55%) patients had an aortic homograft, 53 (25%) patients had a pulmonary homograft patch, and 30 (14%) patients had autologous pericardium. Independent of the technique for aortic enlargement, 55 (26%) children had coarctectomy. RESULTS: Eighty patients had a significant arch gradient, as determined by means of echocardiography, and of these, 50 required balloon angioplasty, surgical arch augmentation, or both. Preoperative aortic coarctation was consistently linked to neoaortic arch obstruction (P = .032). Patients having aortic arch enlargement by means of direct connection or with autologous pericardium were less likely to have neoaortic arch obstruction (P = .049). Coarctectomy resulted in a lower incidence of neoaortic arch obstruction, as determined by means of echocardiography (P = .015), or need for reintervention (P = .01). CONCLUSIONS: Patients with hypoplastic left heart syndrome undergoing aortic arch enlargement with autologous tissue are less likely to require intervention for neoaortic arch obstruction compared with those having homograft patch reconstruction. Excision of all ductal tissue by means of coarctectomy reduces the risk of recurrent aortic arch obstruction. An aggressive approach to reconstruction of the arch and the use of autologous tissue at the time of stage I palliation is advocated.
OBJECTIVE:Neoaortic arch obstruction after stage I palliation is an important risk factor affecting interstage mortality in patients with hypoplastic left heart syndrome, with no accepted standard surgical approach. We sought to determine the efficacy of different techniques for aortic arch reconstruction to reduce the incidence of postoperative neoaortic arch obstruction. METHODS: From January 2000 through June 2005, 210 patients underwent stage I palliation. To enlarge the aortic arch, 12 (6%) patients had a direct connection, 115 (55%) patients had an aortic homograft, 53 (25%) patients had a pulmonary homograft patch, and 30 (14%) patients had autologous pericardium. Independent of the technique for aortic enlargement, 55 (26%) children had coarctectomy. RESULTS: Eighty patients had a significant arch gradient, as determined by means of echocardiography, and of these, 50 required balloon angioplasty, surgical arch augmentation, or both. Preoperative aortic coarctation was consistently linked to neoaortic arch obstruction (P = .032). Patients having aortic arch enlargement by means of direct connection or with autologous pericardium were less likely to have neoaortic arch obstruction (P = .049). Coarctectomy resulted in a lower incidence of neoaortic arch obstruction, as determined by means of echocardiography (P = .015), or need for reintervention (P = .01). CONCLUSIONS:Patients with hypoplastic left heart syndrome undergoing aortic arch enlargement with autologous tissue are less likely to require intervention for neoaortic arch obstruction compared with those having homograft patch reconstruction. Excision of all ductal tissue by means of coarctectomy reduces the risk of recurrent aortic arch obstruction. An aggressive approach to reconstruction of the arch and the use of autologous tissue at the time of stage I palliation is advocated.
Authors: Diego Porras; David W Brown; Audrey C Marshall; Pedro Del Nido; Emile A Bacha; Doff B McElhinney Journal: J Am Coll Cardiol Date: 2011-08-16 Impact factor: 24.094
Authors: Jeffrey A Feinstein; D Woodrow Benson; Anne M Dubin; Meryl S Cohen; Dawn M Maxey; William T Mahle; Elfriede Pahl; Juan Villafañe; Ami B Bhatt; Lynn F Peng; Beth Ann Johnson; Alison L Marsden; Curt J Daniels; Nancy A Rudd; Christopher A Caldarone; Kathleen A Mussatto; David L Morales; D Dunbar Ivy; J William Gaynor; James S Tweddell; Barbara J Deal; Anke K Furck; Geoffrey L Rosenthal; Richard G Ohye; Nancy S Ghanayem; John P Cheatham; Wayne Tworetzky; Gerard R Martin Journal: J Am Coll Cardiol Date: 2012-01-03 Impact factor: 24.094
Authors: Hyoungshin Park; Benjamin L Larson; Maxime D Guillemette; Saloni R Jain; Casey Hua; George C Engelmayr; Lisa E Freed Journal: Biomaterials Date: 2010-12-08 Impact factor: 12.479
Authors: Victor Bautista-Hernandez; Mark Scheurer; Ravi Thiagarajan; Joshua Salvin; Frank A Pigula; Sitaram Emani; Francis Fynn-Thompson; Hugo Loyola; Jared Schiff; Pedro J del Nido; Emile A Bacha Journal: Pediatr Cardiol Date: 2010-11-24 Impact factor: 1.655
Authors: Frank J Raucci; Michael D Seckeler; Christine Saunders; James J Gangemi; Benjamin B Peeler; K Anitha Jayakumar Journal: Pediatr Cardiol Date: 2013-05-07 Impact factor: 1.655
Authors: Kevin D Hill; John F Rhodes; Ranjit Aiyagari; G Hamilton Baker; Lisa Bergersen; Paul J Chai; Gregory A Fleming; J Curt Fudge; Matthew J Gillespie; Robert G Gray; Russel Hirsch; Kyong-Jin Lee; Jennifer S Li; Richard G Ohye; Matthew E Oster; Sara K Pasquali; Andrew N Pelech; Wolfgang A K Radtke; Cheryl M Takao; Julie A Vincent; Christoph P Hornik Journal: Circulation Date: 2013-07-17 Impact factor: 29.690
Authors: Ingrid M van Beynum; Serife Kurul; Thomas Krasemann; Michiel Dalinghaus; Pieter van de Woestijne; Jonathan R Etnel; Ad J J C Bogers Journal: World J Pediatr Congenit Heart Surg Date: 2021-07